Fosamprenavir
(Redirected from Telzir)
[edit | edit source]
- Fosamprenavir (Lexiva) is an HIV protease inhibitor used in combination with other antiretroviral agents for the treatment of HIV-1 infection.
What are the uses of this medicine?[edit | edit source]
- Fosamprenavir (Lexiva) in combination with other antiretroviral agents for the treatment of human immunodeficiency virus (HIV-1) infection.
- HIV is the virus that causes AIDS (acquired immune deficiency syndrome).
- Lexiva belongs to a class of anti-HIV medicines called protease inhibitors.
- Lexiva is always used with other anti-HIV medicines.
- When used in combination therapy, Lexiva may help lower the amount of HIV found in your blood, raise CD4+ (T) cell counts, and keep your immune system as healthy as possible, so it can help fight infection.
- However, Lexiva does not work in all patients with HIV.
How does this medicine work?[edit | edit source]
- Fosamprenavir is an antiviral agent.
- Fosamprenavir is a prodrug that is rapidly hydrolyzed to amprenavir by cellular phosphatases in the gut epithelium as it is absorbed.
- Amprenavir is an inhibitor of HIV-1 protease.
- Amprenavir binds to the active site of HIV-1 protease and thereby prevents the processing of viral Gag and Gag-Pol polyprotein precursors, resulting in the formation of immature non-infectious viral particles.
Who Should Not Use this medicine ?[edit | edit source]
This medicine cannot be used in patients who: are taking certain other medicines:
- HALCION® (triazolam; used for insomnia)
- Ergot medicines: dihydroergotamine, ergonovine, ergotamine, and methylergonovine such as CAFERGOT®, MIGRANAL®, D.H.E. 45®, ergotrate maleate, METHERGINE®, and others (used for migraine headaches)
- PROPULSID® (cisapride), used for certain stomach problems
- VERSED® (midazolam), used for sedation
- ORAP® (pimozide), used for Tourette’s disorder
are allergic to Lexiva or any of its ingredients.
- are allergic to AGENERASE (amprenavir).
- You should not take AGENERASE (amprenavir) and Lexiva at the same time.
What drug interactions can this medicine cause?[edit | edit source]
Tell your doctor and pharmacist what other prescription and nonprescription medications, vitamins, and nutritional supplements you are taking. Be sure to mention any of the following:
- alfuzosin (Uroxatral)
- cisapride (Propulsid) (not available in the US)
- delavirdine (Rescriptor); ergot medications such as dihydroergotamine
- (D.H.E. 45, Migranal), ergoloid mesylates (Hydergine), ergonovine, ergotamine (Ergomar, in Cafergot, in Migergot), and methylergonovine (Methergine)
- lomitapide (Juxtapid)
- lovastatin (Altoprev)
- midazolam (Versed)
- pimozide (Orap)
- rifampin (Rifadin, Rimactane, in Rifater, in Rifamate)
- sildenafil (only Revatio brand used for lung disease)
- simvastatin (Zocor, in Vytorin)
- St. John's wort
- triazolam (Halcion)
- anticoagulants ('blood thinners') such as warfarin (Coumadin, Jantoven); antidepressants such as amitriptyline, imipramine (Surmontil),
- paroxetine (Brisdelle, Paxil, Pexeva), and trazodone
- atorvastatin (Lipitor, in Caduet)
- antacids containing aluminum and magnesium (Maalox, others)
- benzodiazepines such as alprazolam (Xanax), clorazepate (Gen-Xene, Tranxene), diazepam (Diastat, Valium), and flurazepam
- bosentan (Tracleer)
- calcium channel blockers such as amlodipine (Norvasc, in Exforge, others), diltiazem (Cardizem, Cartia, Tiazac, others), felodipine, isradipine, nicardipine (Cardene), nifedipine (Adalat, Afeditab CR, Procardia), nimodipine (Nymalize), nisoldipine (Sular), and verapamil (Calan, Covera, Verelan, in Tarka)
- colchicine (Colcrys, Mitigare)
- dasatinib (Sprycel)
- dexamethasone
- everolimus (Afinitor)
- fentanyl (Duragesic)
- fluticasone (Flonase, Flovent, in Advair)
- histamine H2-receptor blockers such as cimetidine, famotidine (Pepcid), nizatidine (Axid), and ranitidine (Zantac); ibrutinib (Imbruvica)
- itraconazole (Onmel, Sporanox)
- medications for irregular heartbeat such as amiodarone (Nexterone, Pacerone), disopyramide (Norpace), lidocaine (Lidoderm; in Xylocaine with Epinephrine), and quinidine (in Nuedexta)
- ketoconazole (Nizoral)
- nilotinib (Tasigna)
- medications for seizures such as carbamazepine (Carbatrol, Epitol, Equetro, Tegretol, others), phenobarbital, and phenytoin (Dilantin, Phenytek); medications that suppress the immune system such as cyclosporine (Gengraf, Neoral, Sandimmune), sirolimus (Rapamune), or tacrolimus (Astagraf XL, Prograf)
- methadone (Dolophine, Methadose)
- other medications to treat HIV including dolutegravir (Tivicay), efavirenz (Sustiva, in Atripla), indinavir (Crixivan), lopinavir (Kaletra), maraviroc (Selzentry), nelfinavir (Viracept), nevirapine (Viramune), raltegravir (Isentress), ritonavir (Norvir, in Kaletra, in Viekira Pak), and saquinavir (Invirase)
- certain medications to treat hepatitis C virus including boceprevir (no longer available in U.S.; Victrelis), paritaprevir (in Viekira XR), and simeprevir (no longer available in U.S.; Olysio)
- certain phosphodiesterase inhibitors (PDE-5 inhibitors) used for erectile dysfunction such as sildenafil (Viagra), tadalafil (Cialis), and vardenafil (Levitra)
- quetiapine (Seroquel)
- rifabutin (Mycobutin)
- salmeterol (Serevent, in Advair)
- tadalafil (Adcirca)vinblastine
Is this medicine FDA approved?[edit | edit source]
- The US Food and Drug Administration (FDA) approved it on 20 October 2003, while the European Medicines Agency (EMA) approved it on 12 July 2004.
How should this medicine be used?[edit | edit source]
Recommended dosage: Therapy-Naive Adults:
- Lexiva 1,400 mg twice daily
- Lexiva 1,400 mg once daily plus ritonavir 200 mg once daily
- Lexiva 1,400 mg once daily plus ritonavir 100 mg once daily
- Lexiva 700 mg twice daily plus ritonavir 100 mg twice daily
Protease Inhibitor-Experienced Adults:
- Lexiva 700 mg twice daily plus ritonavir 100 mg twice daily.
Pediatric Patients (2 to 18 years of age):
- Dosage should be calculated based on body weight (kg) and should not exceed adult dose.
Hepatic Impairment:
- Recommended adjustments for patients with mild, moderate, or severe hepatic impairment.
Administration:
- Fosamprenavir comes as a tablet and a suspension (liquid) to take by mouth.
- It is usually taken once or twice a day.
- The tablets can be taken with or without food. In patients at least 18 years old, the suspension should be taken without food.
- In patients younger than 18 years old, the suspension should be taken with food.
- If you are taking the suspension, shake it well before each use to mix the medication evenly.
- If you vomit less than 30 minutes after you take fosamprenavir, you should take another full dose of fosamprenavir.
What are the dosage forms and brand names of this medicine?[edit | edit source]
This medicine is available in fallowing doasage form:
- As 700 mg tablets and 50 mg/mL oral suspension
This medicine is available in fallowing brand namesː
- Lexiva
What side effects can this medication cause?[edit | edit source]
The most common side effects of this medicine include:
- skin rash
- diabetes and high blood sugar (hyperglycemia)
- increased bleeding problems in some patients with hemophilia
- worse liver disease
- changes in blood tests
- changes in body fat
- kidney stones
- nausea
- vomiting
- diarrhea
What special precautions should I follow?[edit | edit source]
- Certain drugs should not be coadministered with Lexiva due to risk of serious or life-threatening adverse reactions.
- Lexiva should be discontinued for severe skin reactions including Stevens-Johnson syndrome. Lexiva should be used with caution in patients with a known sulfonamide allergy.
- Use of higher than approved doses may lead to transaminase elevations. Patients with hepatitis B or C are at increased risk of transaminase elevations.
- Patients receiving Lexiva may develop new onset or exacerbations of diabetes mellitus, hyperglycemia , immune reconstitution syndrome, redistribution/accumulation of body fat, and elevated triglyceride and cholesterol concentrations. Monitor cholesterol and triglycerides prior to therapy and periodically thereafter.
- Acute hemolytic anemia has been reported with amprenavir.
- Spontaneous bleeding may occur, and additional factor VIII may be required.
- Cases of nephrolithiasis have been reported with fosamprenavir. If signs or symptoms of nephrolithiasis occur, temporary interruption or discontinuation of therapy may be considered.
- Lexiva should be used with caution in patients with a known sulfonamide allergy. Fosamprenavir contains a sulfonamide moiety.
- Immune reconstitution syndrome has been reported in patients treated with combination antiretroviral therapy, including Lexiva.
- Redistribution/accumulation of body fat, including central obesity, dorsocervical fat enlargement (buffalo hump), peripheral wasting, facial wasting, breast enlargement, and “cushingoid appearance,” have been observed in patients receiving antiretroviral therapy, including Lexiva.
- Treatment with Lexiva plus ritonavir has resulted in increases in the concentration of triglycerides and cholesterol. Triglyceride and cholesterol testing should be performed prior to initiating therapy with Lexiva and at periodic intervals during therapy.
- Patients should be instructed to shake the bottle vigorously before each use and that refrigeration of the oral suspension may improve the taste for some patients.
- Patients should be informed that Lexiva is not a cure for HIV infection and that they may continue to develop opportunistic infections and other complications associated with HIV disease.
What to do in case of emergency/overdose?[edit | edit source]
Symptoms of overdosage may include:
- transaminase elevations
Management of overdosage:
- There is no known antidote for Lexiva.
- It is not known whether amprenavir can be removed by peritoneal dialysis or hemodialysis.
- If overdosage occurs, the patient should be monitored for evidence of toxicity and standard supportive treatment applied as necessary.
Can this medicine be used in pregnancy?[edit | edit source]
- Pregnancy Category C.
- There are no adequate and well-controlled studies in pregnant women.
- Lexiva should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.
Can this medicine be used in children?[edit | edit source]
- No data are available for pediatric patients <2 years of age.
- The safety, pharmacokinetic profile, and virologic response of Lexiva Oral Suspension and Tablets were evaluated in pediatric patients 2 to 18 years of age.
What are the active and inactive ingredients in this medicine?[edit | edit source]
Active Ingredient:
- fosamprenavir calcium.
Inactive Ingredients:
- colloidal silicon dioxide, croscarmellose sodium, magnesium stearate, microcrystalline cellulose, and povidone K30. The tablet film-coating contains the inactive ingredients hypromellose, iron oxide red, titanium dioxide, and triacetin.
Who manufactures and distributes this medicine?[edit | edit source]
- Lexiva and AGENERASE are registered trademarks of GlaxoSmithKline.
- GlaxoSmithKline Vertex Pharmaceuticals Incorporated
- Research Triangle Park, NC 27709 Cambridge, MA
What should I know about storage and disposal of this medication?[edit | edit source]
- Lexiva Tablets should be stored at room temperature between 59° and 86°F (15° to 30°C).
- Keep the container of Lexiva Tablets tightly closed.
- Lexiva Oral Suspension may be stored at room temperature or refrigerated.
- Refrigeration of Lexiva Oral Suspension may improve taste for some patients.
- Do not freeze.
- Keep Lexiva and all medicines out of the reach of children.
- Do not keep medicine that is out of date or that you no longer need.
- Be sure that if you throw any medicine away, it is out of the reach of children.
Fosamprenavir Resources | |
---|---|
|
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Deepika vegiraju